Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Sep 26, 2026
VGT ETF: Evaluating the Path to the $150 Price Target

VGT ETF: Evaluating the Path to the $150 Price Target

Key Takeaways

  • The selected price target is $150, roughly 24% above VGT's recent trading range near $121 and consistent with Wall Street's average 12-month objective for the fund's underlying holdings.
  • Strong AI-driven earnings growth across mega-cap holdings, particularly NVDA, AAPL, and MSFT, is the primary bullish driver.
  • Concentration risk is the biggest obstacle: the fund's top three stocks account for more than 40% of its weighting, amplifying drawdowns when tech falters.
  • Key technical levels include the 52-week high near $126 as near-term resistance and the recent low near $108 as important support.
  • Analyst consensus implies meaningful upside, but a move to $150 would likely require continued AI capital spending and stable or lower interest rates.

A Closer Look at the VGT ETF

The Vanguard Information Technology ETF (VGT) tracks the MSCI US Investable Market Information Technology 25/50 Index. It provides exposure to large-, mid-, and small-cap U.S. information technology companies under the GICS classification. With an expense ratio near 0.09% and assets under management between $140 billion and $170 billion, VGT stands out as one of the largest options for targeted technology exposure.

VGT's Recent Trading Range and Key Holdings

VGT has recently traded near $121, within its 52-week range of about $83 to $126. Its heavy concentration in mega-cap names means price action tends to mirror a small group of leaders. Nvidia (NVDA), Apple (AAPL), and Microsoft (MSFT) make up a large portion of the portfolio, with additional exposure to Broadcom (AVGO), AMD, Micron (MU), and Oracle (ORCL). This setup drives much of the growth potential while also concentrating risk.

Why the $150 Level Stands Out

The $150 target is not random. Aggregate 12-month price objectives for VGT's holdings have recently clustered between $144 and $154, with some forecasts reaching as high as $205. Technical analysis also points to a measured-move objective around $150 to $151 based on the scale of the prior advance. This alignment of analyst views and chart projections gives the level added significance.

Factors That Could Support Further Gains

Ongoing spending on artificial intelligence infrastructure, cloud computing, and semiconductors represents the clearest catalyst. When the largest holdings deliver strong earnings growth, the weighted index has historically converted that into solid returns. A stable or declining interest-rate environment would further support valuations in this growth-oriented sector. VGT's elevated beta can amplify those gains relative to broader benchmarks when conditions align.

Key Risks to the Upside Scenario

Portfolio concentration remains the primary concern. Because NVDA, AAPL, and MSFT dominate the holdings, any disappointment in those names transmits directly to the fund. VGT has also tended to decline more sharply than the S&P 500 during past market pullbacks. Higher valuations, sustained high interest rates, or a slowdown in AI-related capital expenditures could all complicate the path higher.

Important Technical Levels to Watch

The 52-week high near $126 serves as the immediate resistance that would need to be cleared for the $150 target to come into clearer view. On the downside, the recent low around $108 acts as meaningful support; a break below that area would undermine the bullish setup. The longer-term uptrend that has lifted the fund from the low $80s remains intact provided those support zones hold.

Analyst Consensus on the Underlying Holdings

Ratings across VGT's components stay predominantly positive, with far more Buy ratings than Sells. The average 12-month price target for those holdings has ranged from roughly $144 to $154, and some high-end estimates exceed $195. This positions the $150 objective as ambitious yet still within the range of mainstream forecasts.

Final Assessment

The $150 target for VGT looks plausible but depends on several conditions holding. It matches the average analyst objective derived from the holdings and aligns with technical projections from the prior advance. Continued AI-driven earnings strength from the mega-cap leaders and a supportive rate environment represent the main tailwinds. The chief risks remain the fund's concentration, its higher volatility, and its tendency to fall more than the broader market during corrections. A decisive move above the 52-week high near $126, sustained earnings momentum from NVDA, AAPL, and MSFT, and steady interest-rate expectations will all influence whether the target stays in play. When reviewing the technical setup, I also checked this using Tickeron’s AI Screener to see how the fund compares to other technology vehicles.

Monitoring Market Signals with Tickeron Tools

Investors tracking whether VGT can approach its price target may find value in real-time indicators that adapt to shifting conditions. Tickeron's AI Daily Buy/Sell Signals apply artificial intelligence to scan thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on technical behavior and market dynamics. I have used these signals in my own process to spot emerging opportunities and reassess existing positions more efficiently, particularly when evaluating sector-focused ETFs like VGT.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: VGT

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


Aroon Indicator for VGT shows an upward move is likely

VGT's Aroon Indicator triggered a bullish signal on September 25, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 348 similar instances where the Aroon Indicator showed a similar pattern. In 317 of the 348 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 16, 2026. You may want to consider a long position or call options on VGT as a result. In 76 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 86%.

The Moving Average Convergence Divergence (MACD) for VGT just turned positive on September 18, 2026. Looking at past instances where VGT's MACD turned positive, the stock continued to rise in 43 of 52 cases over the following month. The odds of a continued upward trend are 83%.

VGT moved above its 50-day moving average on August 25, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +3.35% 3-day Advance, the price is estimated to grow further. Considering data from situations where VGT advanced for three days, in 339 of 388 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.

Bearish Trend Analysis

The 10-day RSI Indicator for VGT moved out of overbought territory on September 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 43 similar instances where the indicator moved out of overbought territory. In 32 of the 43 cases, the stock moved lower in the following days. This puts the odds of a move lower at 74%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VGT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

VGT broke above its upper Bollinger Band on September 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Apple (NASDAQ:AAPL), Microsoft Corp (NASDAQ:MSFT), Broadcom Inc. (NASDAQ:AVGO), Micron Technology (NASDAQ:MU), Advanced Micro Devices (NASDAQ:AMD), Intel Corp (NASDAQ:INTC), Cisco Systems (NASDAQ:CSCO), Oracle Corp (NYSE:ORCL), Lam Research Corp (NASDAQ:LRCX).

Industry description

The investment seeks to track the performance of the MSCI U.S. Investable Market Index/Information Technology 25/50. The fund employs an indexing investment approach designed to track the performance of the index, an index made up of stocks of large, mid-size, and small U.S. companies within the information technology sector, as classified under the GICS. The Advisor attempts to replicate the target index by seeking to invest all of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. It is non-diversified.

Market Cap

The average market capitalization across the Vanguard Information Technology ETF (VGT) ETF is 84.36B. The market cap for tickers in the group ranges from 48.94M to 5.43T. NVDA holds the highest valuation in this group at 5.43T. The lowest valued company is MVIS at 48.94M.

High and low price notable news

The average weekly price growth across all stocks in the Vanguard Information Technology ETF (VGT) ETF was 3%. For the same ETF, the average monthly price growth was 7%, and the average quarterly price growth was 49%. EGHT experienced the highest price growth at 30%, while ALKT experienced the biggest fall at -28%.

Volume

The average weekly volume growth across all stocks in the Vanguard Information Technology ETF (VGT) ETF was -50%. For the same stocks of the ETF, the average monthly volume growth was 7% and the average quarterly volume growth was -41%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 62
P/E Growth Rating: 56
Price Growth Rating: 46
SMR Rating: 68
Profit Risk Rating: 75
Seasonality Score: -16 (-100 ... +100)
View a ticker or compare two or three
VGT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Technology

Category
Technology
Address
Vanguard Health CarePo Box 2600 V26Valley Forge
Phone
N/A
Web
www.vanguard.com
Interact to see
Advertisement
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Shares of Enliven Therapeutics (ELVN) are surging approximately +15% in premarket trading on March 25, 2026, driven by renewed investor enthusiasm around the company's advancing clinical program for ELVN-001 in chronic myeloid leukemia (CML). The stock's prior closing price on March 24, 2026 was $31.15, placing the premarket indicated price near $35.82.
AVXL shares are down approximately 29% in premarket trading on Wednesday, March 25, 2026, falling to roughly $2.97 from the prior close of $4.19. The primary catalyst is Anavex's formal withdrawal of its marketing authorization application (MAA) for blarcamesine from the European Union, announced in the early hours of March 25, 2026.